Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16062301 | LX1606 (Hippurate) | 1137608-69-5 | 98% by HPLC | -cas-1137608-69-5.png) |
| LX1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibi | ||||
| 632801 | Lumateperone(ITI-007) | 313368-91-1 | 98% | -cas-313368-91-1.png) |
| ITI-007 is an investigational atypical antipsychotic which is currently under develop | ||||
| 030907 | LGD-4033(Ligandrol) | 1165910-22-4 | 98% | -cas-1165910-22-4.png) |
| LGD-4033, also known as VK5211 and Ligandrol, is an investigational selective androge | ||||
| 011904 | LY-379268 | 191471-52-0 | 98% |  |
| Coming soon! | ||||
| 011808 | Lefamulin acetate | 1350636-82-6 | 98% |  |
| Coming soon! | ||||
| 011807 | Lefamulin | 1061337-51-6 | 98% |  |
| Coming soon! | ||||
| 011316 | L-165041 | 79558-09-1 | 98% |  |
| Coming soon! | ||||
| 010819 | Linsitinib | 867160-71-2 | 98% |  |
| Linsitinib is highly potent, orally efficacious and highly selective, dual ATP-compet | ||||
| 010815 | Lestaurtinib | 111358-88-4 | 98% |  |
| Lesraurtinib is an orally bioavailable indolocarbazole derivative with antineoplastic | ||||
| 010802 | LX7101 | 1192189-69-7 | 98% |  |
| LX7101 is a potent inhibitor of LIMK1/2, ROCK2 and PKA, with IC50 of 24/1.6, 10, and | ||||
| 010435 | Loratadine | 79794-75-5 | 98% |  |
| Loratadine is a selective inverse peripheral histamine H1-receptor agonist with an IC | ||||
| 122909 | LY2584702 free base | 1082949-67-4 | 98% |  |
| LY2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and p | ||||
| 122907 | LY2584702 tosylate | 1082949-68-5 | 98% |  |
| LY-2584702 tosylate salt is an orally available inhibitor of p70S6K signaling; inhibi | ||||
| 122835 | L-779450 | 303727-31-3 | 98% |  |
| L-779450 is a potent, selective and ATP-competitive Raf kinase inhibitor (IC50 = 10 n | ||||
| 122830 | LDN193189 Hydrochloride | 1062368-62-0 | 98% |  |
| LDN193189 Hydrochloride is a selective BMP signaling inhibitor, inhibits the transcri | ||||
| 122820 | LCL161 | 1005342-46-0 | 98% |  |
| LCL161 is an orally bioavailable SMAC mimetic and inhibitor of Inhibitor of Apoptosis | ||||
| 122803 | Lexibulin | 917111-44-5 | 98% |  |
| Lexibulin is an orally bioavailable small-molecule with tubulin-inhibiting, vascular- | ||||
| 122509 | LY2228820 | 862507-23-1 | 98% |  |
| LY2228820 is a novel and potent p38MAPK inhibitor (the IC50 for p38MAPK and p38MAPK w | ||||
| 122218 | LY2608204 | 1234703-40-2 | 98% |  |
| LY2608204 is a activator of glucokinase (GK) with EC50 of 42 nM. | ||||
| 121805 | L-778123 hydrochloride | 253863-00-2 | 98% |  |
| L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and | ||||
| 121506 | Laquinimod | 248281-84-7 | 98% |  |
| Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. | ||||
| 121435 | LY2811376 | 1194044-20-6 | 98% |  |
| LY2811376 is a BACE1 inhibitor with marked Ab-lowering effects in animal models. | ||||
| 121427 | LY2886721 | 1262036-50-9 | 98% |  |
| LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease. | ||||
| 121416 | Linifanib | 796967-16-3 | 98% |  |
| Linifanib is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR, CSF-1R, F | ||||
| 5121102 | LY2090314 | 603288-22-8 | 98% by HPLC |  |
| LY2090314 (LY) is a glycogen synthase kinase 3 inhibitor with preclinical efficacy in | ||||
| 120422 | LMK 235 | 1418033-25-6 | 98% |  |
| LMK 235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor, which demons | ||||
| 110606 | LDN-57444 | 668467-91-2 | 98% |  |
| LDN-57444 is a Uch-L1 inhibitor with Ki= 0.4 M. Ubiquitin carboxy-terminal hydrolase | ||||
| 110603 | Leuprolide | 53714-56-0 | 98% |  |
| Leuprolide is an agonist at pituitary GnRH receptors. | ||||
| 101914 | LY2409881 trihydrochloride | 946518-60-1 | 98% |  |
| LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; | ||||
| 91810 | LHW090-A7 | 1308256-94-1 | 98% |  |
| Coming soon! | ||||